Journal of Market Access & Health Policy

J Mark Access Health Policy

2001-6689

Therapeutic Area

Artificial Intelligence, Epidemiology, Health Economics/Outcomes Research, Health Policy, Health Services, Health Services Research, Medical Communications, Medical Technology, Pharmacology, Regenerative Medicine, Statistics

Academicians, Administrators, Artificial Intelligence Researcher, Biomedical Researchers, Epidemiologists, Health Scientists, Health Service Researchers, Healthcare Executives, Outcomes Manager, Pharmacologists, Policy Makers, Statisticians

Aim: Journal of Market Access & Health Policy (ISSN 2001-6689) is an open access publication focused on the concept of “market access” from economic, technical, scientific, sociological, psychological, and policy perspectives. Journal of Market Access & Health Policy (JMAHP) is the official journal of the Market Access Society. Market access is a new discipline at the crossroads of several disciplines, including pharmacology, clinical trials, statistics, econometrics, epidemiology, pricing, psychology, policy, and Health Technology Assessment (HTA). It is a multifaceted area ultimately impelled by making innovative therapies available to patients. It has only been recognized as a topic in itself in recent times, and the book by Professor Mondher Toumi, Introduction to Market Access for Pharmaceuticals (1st ed.; CRC Press, 2017), founded the discipline. Journal of Market Access & Health Policy aims to link all of the components that impact “market access” and provide a convergent, broader perspective within a single, specialized journal. Journal of Market Access & Health Policy serves as a reference desk for industry, regulators, academics, clinicians, and other professionals within the medical and allied health fields providing innovative research articles, discussion papers on the best practices, and valuable guidelines. Scope: The main research areas include (but are not limited to): Market Access Environment and International Health Policy Comparison: health environment, health policies, and market access regulations across a broad range of countries. Pricing and Reimbursement: price policy and strategy, pricing and reimbursement environment, risk evaluation, reimbursement evaluation. Health Economics and Outcome Research: cost-effectiveness analysis, budget impact analysis, methodology, guidelines. Market Access for Vaccines, Medical Devices, and Diagnostics: regulation, classification, and certification Health Technology Assessment (HTA) and National Immunization Technical Advisory Groups (NITAGs); innovation and future challenges, value-based pricing for diagnostics and devices. Market Access Activities: market access strategy, health technology assessment, literature review, market access agreements, market access of specific products. Public Health: decision making, monitoring, and evaluation. Market Access of Orphan Drugs: pricing process, HTA framework, future perspective. Regenerative Medicine: marketing authorization, HTA, pricing, reimbursement, affordability, payment, and partnership agreements of regenerative medicines and commercialization. Artificial Intelligence in Healthcare: predicting HTA outcomes, data extraction, visualization of healthcare pathways, automated systematic literature reviews, generative data.

Market Access Society (MAS)

MDPI Publishing

Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines